Stabilized micelles as delivery vehicles for paclitaxel

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 258-264

  Yoncheva, Krassimira ^a   Calleja, Patricia ^b   Agüeros, Maite ^b   Petrov, Petar ^c   Miladinova, Ivanka ^a   Tsvetanov, Christo ^c   Irache, Juan M ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUTE OF POLYMERS   (Bulgaria)

Author keywords

Gastrointestinal transit; Oral absorption; Paclitaxel; Pluronic; Stabilized micelles

Indexed keywords

PACLITAXEL; POLOXAMER; RHODAMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; ENCAPSULATION; EVAPORATION; FEMALE; GASTROINTESTINAL TRANSIT; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACRYLATES; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; FEMALE; GASTROINTESTINAL TRANSIT; MICE; MICE, INBRED C57BL; MICELLES; PACLITAXEL; POLOXAMER; PROPYLENE GLYCOLS; RATS; RATS, WISTAR;

EID: 84865294345     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.030     Document Type: Article

References (40)

1. M. Agüeros, V. Zabaleta, S. Espuelas, M.A. Campanero, and J.M. Irache Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles J. Control. Release 145 2010 2 8
2. P. Alexandridis, and T.A. Hatton Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling Colloids Surf. A: Physicochem. Eng. Aspects 96 1995 1 46
3. C. Allen, Y. Yu, A. Eisenberg, and D. Maysinger Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles Biochim. Biophys. Acta 1421 1999 32 38
4. P. Arbos, M.A. Arangoa, M.A. Campanero, and J.M. Irache Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles Int. J. Pharm. 242 2002 129 136
5. T. Bansal, N. Akhtar, M. Jaggi, R.K. Khar, and S. Talegaonkar Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation Drug Discov. Today 14 2009 1067 1074
6. E.V. Batrakova, H.Y. Han, V. Alakhov, D.W. Miller, and A.V. Kabanov Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers Pharm. Res. 15 1998 850 855
7. E.V. Batrakova, H.Y. Han, D.W. Miller, and A.V. Kabanov Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells Pharm. Res. 15 1998 1525 1532
8. E.V. Batrakova, S. Li, Y. Li, V.Y. Alakhov, and A.V. Kabanov Effect of pluronic P85 on ATPase activity of drug efflux transporters Pharm. Res. 21 2004 2226 2233
9. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
10. A.V. Boddy, E.R. Plummer, R. Todd, J. Sludden, M. Griffin, L. Robson, J. Cassidy, D. Bissett, A. Bernareggi, M. Verrill, and A. Calvert A Phase I and pharmacokinetic study of paclitaxel poliglumex (Xyotax), investigating both 3-weekly and 2-weekly schedules Clin. Cancer Res. 11 2005 7834 7840
11. Q. Chen, Q.Z. Zhang, J. Liu, L.Q. Li, W.H. Zhao, Y.J. Wang, Q.H. Zhou, and L. Li Multi-center prospective randomized trial on paclitaxel liposome and traditional taxol in the treatment of breast cancer and non-small-cell lung cancer Chin. J. Oncol. 25 2003 190 192
12. M.L. Forrest, J.A. Yanez, C.M. Remsber, Y. Ohgami, G.S. Kwon, and N.M. Davies Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol-b-poly((-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity Pharm. Res. 25 2008 194 206
13. G. Gaucher, P. Satturwar, M.C. Jones, A. Furtos, and J.C. Leroux Polymeric micelles for oral drug delivery Eur. J. Pharm. Biopharm. 76 2010 147 158
14. R.E. Gregory, and A.F. DeLisa Paclitaxel: a new antineoplastic agent for refractory ovarian cancer Clin. Pharm. 12 1993 401 415
15. T. Hamaguchi, Y. Matsumura, M. Suzuki, K. Shimizu, R. Goda, I. Nakamura, I. Nakatomi, M. Yokoyama, K. Kataoka, and T. Kakizoe NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel Br. J. Cancer 92 2005 1240 1246
16. L.M. Han, J. Guo, L.J. Zhang, Q.S. Wang, and X.L. Fang Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123 Acta Pharmacol. Sin. 27 2006 747 753
17. J. Huang, L. Si, L. Jiang, Z. Fan, J. Qiu, and G. Li Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism Int. J. Pharm. 356 2008 351 353
18. M.C. Jones, and J.C. Leroux Polymeric micelles - a new generation of colloidal drug carriers Eur. J. Pharm. Biopharm. 48 1999 101 111
19. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Deliv. Rev. 54 2002 759 779
20. A.V. Kabanov, E.V. Batrakova, and V.J. Alakhov Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery J. Control. Release 82 2002 189 212
21. J. Koziara, T. Whisman, M. Tseng, and R.J. Mumper In vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors J. Control. Release 112 2006 312 319
22. K. Letchford, R. Liggins, K.M. Wasan, and H. Burt In vitro human plasma properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles Eur. J. Pharm. Biopharm. 71 2009 196 206
23. F. Li, T. Ketelaar, A.T.M. Marcelis, F.A.M. Leermakers, M.A. Cohen Stuart, and E.J.R. Sudhölter Stabilization of polymersome vesicles by an interpenetrating polymer network Macromolecules 40 2007 329 333
24. L. Luo, J. Tam, D. Maysinger, and A. Eisenberg Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles Bioconjug. Chem. 13 2002 1259 1265
25. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284
26. M.M. Malingre, J.H. Beijnen, and J.H. Schellens Oral delivery of taxanes Invest. New Drugs 19 2001 155 162
27. F. Mathot, A. des Rieux, A. Ariën, Y.J. Schneider, M. Brewster, and V. Préat Transport mechanism of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier J. Control. Release 124 2007 134 143
28. N. Onetto, R. Canetta, B. Winograd, R. Catane, M. Dougan, J. Grechko, J. Burroughs, and M. Rozencweig Overview of Taxol safety J Natl. Cancer Inst. Monogr. 15 1993 131 139
29. P. Petrov, M. Bozukov, M. Burkhardt, S. Muthukrishnan, A.H.E. Mueller, and Ch. Tsvetanov Stabilization of polymeric micelles with a mixed poly(ethylene oxide)/poly(2-hydroxyethyl methacrylate) shell by formation of poly(pentaerythritol tetraacrylate) nanonetworks within the micelles J. Mater. Chem. 16 2006 2192 2199
30. P. Petrov, Y. Jiayin, K. Yoncheva, A. Müller, and Ch. Tsvetanov Wormlike morphology formation and stabilization of Pluronic P123 micelles by solubilization of pentaerythritol tetraacrylate J. Phys. Chem. B 112 2008 8879 8883
31. N. Rapoport Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery Colloids Surf. B: Biointerfaces 16 1999 93 111
32. V. Roy, B.R. LaPlant, G.G. Gross, C.L. Bane, and F.M. Palmieri Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531) Ann. Oncol. 20 2009 449 453
33. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
34. A. Sparreboom, L. van Zuylen, E. Brouwer, W. Loos, P. de Bruijn, H. Gelderblom, M. Pillay, K. Nooter, G. Stoter, and J. Verweij Cremophor EL-mediated alteration of paclitaxel distribution inhumanblood: clinical pharmacokinetic implications Cancer Res. 59 1999 1454 1457
35. H. Thomas, and H.M. Coley Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein Cancer Control 10 2003 159 165
36. V.P. Torchilin Targeted polymeric micelles for delivery of poorly soluble drugs Cell Mol. Life Sci. 61 2004 2549 2559
37. X. Wang, H. Zheng, Z. Zhu, Y. Wei, and L. Chen Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography J. Pharm. Sci. 99 2010 4746 4752
38. K.Y. Win, and S.S. Feng In vitro and in vivo studies on vitamin E TPGS-emulsified poly(d,l-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation Biomaterials 27 2006 2285 2291
39. K. Yoncheva, L. Guembe, M.A. Campanero, and J.M. Irache Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles Int. J. Pharm. 334 2007 156 165
40. L. Zhao, Y. Ye, J. Li, and Y.M. Wei Preparation and the in vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs J. Pharm. Pharmacol. 63 2011 80 86